Novo Holdings, a global life science investor, has co-led the Series A financing of its portfolio company, Muna Therapeutics (Muna), which is pioneering the development of first-in-class small molecule therapeutics for neurodegenerative diseases. The financing also includes Sofinnova Partners, Droia Ventures and LSP Dementia Fund with participation from Polaris Partners,
Novo Holdings, an international investor in healthcare and life sciences, has made a strategic minority investment in Availity, one of the largest healthcare data and administrative networks connecting payers and providers throughout the United States. Availity is a leader in payer-provider collaboration. Through its digital provider engagement, clearinghouse, and revenue
Transatlantic growth-stage venture capital fund Blisce has led a EUR15 million round into home help and well-being services startup Wesaca, with participation from existing investors Serena and ISAI, as well as the co-founder of BlaBlaCar, Frédéric Mazzella. Wecasa offers ‘mobile wellness, beauty, and care services seven days a week, for
Varagon Capital Partners (Varagon) is serving as Administrative Agent, Lead Arranger and Bookrunner on a senior secured credit facility to support the acquisition of Zavation Medical Products (Zavation or the Company) by Gemspring Capital (Gemspring). Based in Flowood, MS, Zavation designs, engineers, and manufactures a portfolio of spinal hardware and
Kuano.ai, a software platform for rapid, cost effective quantum modelling of enzymes, has raised GBP1 million in seed funding from ACF Investors, o2h Ventures and a syndicate of Cambridge-based angel investors. The funding will accelerate the company’s growth as it moves further towards commercialisation. Kuano combines quantum physics, artificial intelligence
Listed private equity and infrastructure investment manager Foresight Group, has made a GBP1.5 million follow-on investment in portfolio company Biotherapy Services Ltd (BTS), a pharmaceutical biotech company. The funds will be used to support the clinical development of RAPIDTM Biodynamic Haematogel, currently in phase 2b/3 clinical trials in the treatment
US Orthopaedic Partners (USOP), a comprehensive orthopedic care platform that provides the full continuum of musculoskeletal treatment to patients in the Southeastern US, is to enter into a strategic partnership with Andrews Sports Medicine & Orthopaedic Center in Birmingham, Alabama. US Orthopaedic Partners is to partner with Andrews Sports Medicine &
The Life Sciences Investment Programme, previously announced by the Chancellor of the Exchequer, has opened for applications from fund managers. To be delivered by British Patient Capital, a commercial subsidiary of British Business Bank, the programme will bring more large-scale specialist UK focused fund managers to market, increasing the supply
Walter Capital Partners (Walter Capital) has partnered with Clareo Dental Network (Clareo), the largest domestic network of dental clinics in Québec, to propel its growth. This transaction marks Walter Capital’s 14th investment in Canadian businesses with high growth potential. “Walter Capital has a vast experience in the health
QV Bioelectronics (QV) – a medical device start-up pioneering a first of its kind electric field therapy implant for the treatment of the most common and aggressive type of brain tumours, has closed a GBP735,000 seed funding round to advance the development of its innovative GRACE implant. The round
12 November, 2026 – 5:00 pm
12 November, 2026 – 8:00 am
12 February, 2026 – 8:00 am
12 February, 2026 – 5:00 pm
